ArticleCancer medicine2017

GPX3 methylation in bone marrow predicts adverse prognosis and leukemia transformation in myelodysplastic syndrome.

Jing-Dong Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.